Literature DB >> 23756464

A DIStinctively novel exoribonuclease that really likes U.

Imed E Gallouzi1, Jeffrey Wilusz.   

Abstract

Regulated degradation plays a major role in determining the levels of both non-coding (miRNA) and coding (mRNA) transcripts. Thus, insights into the factors and pathways that influence this process have broad, interdisciplinary implications. New findings by Malecki et al (2013), Lubas et al (2013), and Chang et al (2013) identify the protein Dis3L2 as a major player in the 3′–5′ exonucleolytic decay of transcripts. Furthermore, they demonstrate a strong connection between terminal uridylation of the RNA substrate and enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23756464      PMCID: PMC3981174          DOI: 10.1038/emboj.2013.136

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  10 in total

1.  Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility.

Authors:  Dewi Astuti; Mark R Morris; Wendy N Cooper; Raymond H J Staals; Naomi C Wake; Graham A Fews; Harmeet Gill; Dean Gentle; Salwati Shuib; Christopher J Ricketts; Trevor Cole; Anthonie J van Essen; Richard A van Lingen; Giovanni Neri; John M Opitz; Patrick Rump; Irene Stolte-Dijkstra; Ferenc Müller; Ger J M Pruijn; Farida Latif; Eamonn R Maher
Journal:  Nat Genet       Date:  2012-02-05       Impact factor: 38.330

2.  Exonuclease hDIS3L2 specifies an exosome-independent 3'-5' degradation pathway of human cytoplasmic mRNA.

Authors:  Michal Lubas; Christian K Damgaard; Rafal Tomecki; Dominik Cysewski; Torben Heick Jensen; Andrzej Dziembowski
Journal:  EMBO J       Date:  2013-06-11       Impact factor: 11.598

3.  TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation.

Authors:  Inha Heo; Chirlmin Joo; Young-Kook Kim; Minju Ha; Mi-Jeong Yoon; Jun Cho; Kyu-Hyeon Yeom; Jinju Han; V Narry Kim
Journal:  Cell       Date:  2009-08-21       Impact factor: 41.582

Review 4.  Regulation of cytoplasmic mRNA decay.

Authors:  Daniel R Schoenberg; Lynne E Maquat
Journal:  Nat Rev Genet       Date:  2012-03-06       Impact factor: 53.242

5.  Conserved RNaseII domain protein functions in cytoplasmic mRNA decay and suppresses Arabidopsis decapping mutant phenotypes.

Authors:  Weiping Zhang; Caroline Murphy; Leslie E Sieburth
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

6.  Degradation of histone mRNA requires oligouridylation followed by decapping and simultaneous degradation of the mRNA both 5' to 3' and 3' to 5'.

Authors:  Thomas E Mullen; William F Marzluff
Journal:  Genes Dev       Date:  2008-01-01       Impact factor: 11.361

7.  The exoribonuclease Dis3L2 defines a novel eukaryotic RNA degradation pathway.

Authors:  Michal Malecki; Sandra C Viegas; Tiago Carneiro; Pawel Golik; Clémentine Dressaire; Miguel G Ferreira; Cecília M Arraiano
Journal:  EMBO J       Date:  2013-03-15       Impact factor: 11.598

8.  Decapping is preceded by 3' uridylation in a novel pathway of bulk mRNA turnover.

Authors:  Olivia S Rissland; Chris J Norbury
Journal:  Nat Struct Mol Biol       Date:  2009-05-10       Impact factor: 15.369

Review 9.  Lin28: primal regulator of growth and metabolism in stem cells.

Authors:  Ng Shyh-Chang; George Q Daley
Journal:  Cell Stem Cell       Date:  2013-04-04       Impact factor: 24.633

10.  A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway.

Authors:  Hao-Ming Chang; Robinson Triboulet; James E Thornton; Richard I Gregory
Journal:  Nature       Date:  2013-04-17       Impact factor: 49.962

  10 in total
  9 in total

1.  Molecular basis for cytoplasmic RNA surveillance by uridylation-triggered decay in Drosophila.

Authors:  Madalena M Reimão-Pinto; Raphael A Manzenreither; Thomas R Burkard; Pawel Sledz; Martin Jinek; Karl Mechtler; Stefan L Ameres
Journal:  EMBO J       Date:  2016-10-11       Impact factor: 11.598

Review 2.  Emerging roles for RNA degradation in viral replication and antiviral defense.

Authors:  Emma Abernathy; Britt Glaunsinger
Journal:  Virology       Date:  2015-02-24       Impact factor: 3.616

3.  A retrovirus packages nascent host noncoding RNAs from a novel surveillance pathway.

Authors:  Matthew J Eckwahl; Soyeong Sim; Derek Smith; Alice Telesnitsky; Sandra L Wolin
Journal:  Genes Dev       Date:  2015-03-15       Impact factor: 11.361

Review 4.  Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine.

Authors:  Sophie L Mumford; Benjamin P Towler; Amy L Pashler; Onur Gilleard; Yella Martin; Sarah F Newbury
Journal:  Biomolecules       Date:  2018-04-26

5.  RNA surveillance by uridylation-dependent RNA decay in Schizosaccharomyces pombe.

Authors:  Christina Z Chung; Julia E Jaramillo; Michael J Ellis; Daniel Y N Bour; Lauren E Seidl; David H S Jo; Matthew A Turk; Mitchell R Mann; Yumin Bi; David B Haniford; Martin L Duennwald; Ilka U Heinemann
Journal:  Nucleic Acids Res       Date:  2019-04-08       Impact factor: 16.971

6.  Structural insights into a unique preference for 3' terminal guanine of mirtron in Drosophila TUTase tailor.

Authors:  Lin Cheng; Fudong Li; Yiyang Jiang; Hailong Yu; Changlin Xie; Yunyu Shi; Qingguo Gong
Journal:  Nucleic Acids Res       Date:  2019-01-10       Impact factor: 16.971

7.  RNA decay during gammaherpesvirus infection reduces RNA polymerase II occupancy of host promoters but spares viral promoters.

Authors:  Ella Hartenian; Sarah Gilbertson; Joel D Federspiel; Ileana M Cristea; Britt A Glaunsinger
Journal:  PLoS Pathog       Date:  2020-02-07       Impact factor: 6.823

Review 8.  Target RNAs Strike Back on MicroRNAs.

Authors:  Federico Fuchs Wightman; Luciana E Giono; Juan Pablo Fededa; Manuel de la Mata
Journal:  Front Genet       Date:  2018-10-02       Impact factor: 4.599

Review 9.  Pre-Ribosomal RNA Processing in Human Cells: From Mechanisms to Congenital Diseases.

Authors:  Maxime Aubert; Marie-Françoise O'Donohue; Simon Lebaron; Pierre-Emmanuel Gleizes
Journal:  Biomolecules       Date:  2018-10-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.